UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 324

Sortiert nach

Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142

Annals of oncology, 2022-10, Vol.33 (10), p.1052-1060

2022

Volltextzugriff (PDF)

Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study

Annals of oncology, 2012-06, Vol.23 (6), p.1525-1530

2012

Volltextzugriff (PDF)

Adjuvant chemotherapy for rectal cancer: Current evidence and recommendations for clinical practice

Cancer treatment reviews, 2020-02, Vol.83, p.101948-101948, Article 101948

2020

Volltextzugriff (PDF)

Total neoadjuvant therapy for rectal cancer: Making sense of the results from the RAPIDO and PRODIGE 23 trials

Cancer treatment reviews, 2021-05, Vol.96, p.102177-102177, Article 102177

2021

Volltextzugriff (PDF)

Treatment compliance in early-stage anal cancer

Annals of oncology, 2020-10, Vol.31 (10), p.1282-1284

2020

Volltextzugriff (PDF)

Phase II study of necitumumab plus modified FOLFOX6 as first-line treatment in patients with locally advanced or metastatic colorectal cancer

British journal of cancer, 2016-02, Vol.114 (4), p.372-380

2016

Volltextzugriff (PDF)

Durable clinical benefit with nivolumab (NIVO) plus low-dose ipilimumab (IPI) as first-line therapy in microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC)

Annals of oncology, 2018-10, Vol.29, p.viii714-viii714

2018

Volltextzugriff (PDF)

New strategies and designs in pancreatic cancer research: consensus guidelines report from a European expert panel

Annals of oncology, 2012-03, Vol.23 (3), p.570-576

2012

Volltextzugriff (PDF)

Grey areas and evidence gaps in the management of rectal cancer as revealed by comparing recommendations from clinical guidelines

Cancer treatment reviews, 2020-01, Vol.82, p.101930, Article 101930

2020

Volltextzugriff (PDF)

Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on 7 days off in patients with advanced, refractory solid tumours

British journal of cancer, 2005-05, Vol.92 (10), p.1855-1861

2005

Volltextzugriff (PDF)

Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study

British journal of cancer, 2006-02, Vol.94 (4), p.481-485

2006

Volltextzugriff (PDF)

Serial FDG–PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapy

Annals of oncology, 2012-07, Vol.23 (7), p.1687-1693

2012

Volltextzugriff (PDF)

Buschke-Löwenstein tumor in a human immunodeficiency virus-positive patient : a case report and short literature review

Acta gastro-enterologica belgica, 2021-04, Vol.84 (2), p.343-345

2021

Volltextzugriff (PDF)

Phase 1 studies assessing the safety and clinical activity of autologous and allogeneic NKG2D-based CAR-T therapy in metastatic colorectal cancer

Annals of oncology, 2019-07, Vol.30, p.iv124-iv125

2019

Volltextzugriff (PDF)

Clinical factors are unable to accurately predict the absence of benefit of surgery in patients operated for resection of colorectal liver metastasis

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii173

2018

Volltextzugriff (PDF)

Phase I studies assessing the safety and clinical activity of multiple doses of a NKG2D-based CAR-T therapy, CYAD-01, in metastatic colorectal cancer

Annals of oncology, 2018-10, Vol.29, p.viii203-viii203

2018

Volltextzugriff (PDF)

Pooled analysis of the surgical treatment for colorectal cancer liver metastases

Critical reviews in oncology/hematology, 2015-04, Vol.94 (1), p.122-135

2015

Volltextzugriff (PDF)

Small cell carcinoma of the esophagus: a multicentre Rare Cancer Network study

Diseases of the esophagus, 2011-05, Vol.24 (4), p.258-264

2011

Volltextzugriff (PDF)

Treatment of colorectal liver metastases: a review

Reviews on recent clinical trials, 2009-01, Vol.4 (1), p.56

2009

Volltextzugriff (PDF)

P-057Body Composition (BC), beyond Body Mass Index (BMI) and sarcopenia, has a major prognostic impact on patients with refractory advanced Colorectal Cancer (aCRC)

Annals of oncology, 2016-06, Vol.27 (suppl_2), p.ii17-ii18

2016

Volltextzugriff (PDF)

Combination of nivolumab (nivo) + ipilimumab (ipi) in the treatment of patients (pts) with deficient DNA mismatch repair (dMMR)/high microsatellite instability (MSI-H) metastatic colorectal cancer (mCRC): CheckMate 142 Study

Annals of oncology, 2017-10, Vol.28, p.vi3-vi3

2017

Volltextzugriff (PDF)

A first-in-human phase I and pharmacokinetic study of CP-4126 (CO-101), a nucleoside analogue, in patients with advanced solid tumours

Cancer chemotherapy and pharmacology, 2015-10, Vol.76 (4), p.785-792

2015

Volltextzugriff (PDF)

Feasibility and safety of a therapeutic strategy using selective transarterial radioembolization followed by surgery for hepatocellular carcinoma in cirrhotic patients

European journal of cancer (1990), 2017-02, Vol.72, p.S84-S85

2017

Volltextzugriff (PDF)

Prospective evaluation of the impact of multidisciplinary meetings on the decision making process in gastro-intestinal oncology

European journal of cancer (1990), 2017-02, Vol.72, p.S53-S53

2017

Volltextzugriff (PDF)

Current practice in approaching controversial diagnostic and therapeutic topics in gastroenteropancreatic neuroendocrine neoplasm management. Belgian multidisciplinary expert discussion based on a modified Delphi method

Acta gastro-enterologica belgica, 2020-10, Vol.83 (4), p.643-653

2020

Volltextzugriff (PDF)

1 – 25 von 324

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(286)
Mit Volltextzugriff
(306)

Publikationsform

Artikel
(317)
Berichte
(6)
Webseiten
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(148)
Life Sciences & Biomedicine
(147)
Humans
(128)
Oncology
(105)
Male
(55)
Female
(53)
Middle Aged
(53)
Tumors
(49)
Aged
(47)
Colorectal Cancer
(43)
Adult
(34)
Chemotherapy
(33)
Treatment Outcome
(33)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(31)
Colorectal Neoplasms - Pathology
(31)
Biological And Medical Sciences
(28)
Medical Sciences
(27)
Metastasis
(27)
Colorectal Neoplasms - Drug Therapy
(26)
Gastroenterology & Hepatology
(26)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142

Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study

Adjuvant chemotherapy for rectal cancer: Current evidence and recommendations for clinical practice

Total neoadjuvant therapy for rectal cancer: Making sense of the results from the RAPIDO and PRODIGE 23 trials

Treatment compliance in early-stage anal cancer

Phase II study of necitumumab plus modified FOLFOX6 as first-line treatment in patients with locally advanced or metastatic colorectal cancer

Durable clinical benefit with nivolumab (NIVO) plus low-dose ipilimumab (IPI) as first-line therapy in microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC)

New strategies and designs in pancreatic cancer research: consensus guidelines report from a European expert panel

Grey areas and evidence gaps in the management of rectal cancer as revealed by comparing recommendations from clinical guidelines

Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on 7 days off in patients with advanced, refractory solid tumours

Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study

Serial FDG–PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapy

Buschke-Löwenstein tumor in a human immunodeficiency virus-positive patient : a case report and short literature review

Phase 1 studies assessing the safety and clinical activity of autologous and allogeneic NKG2D-based CAR-T therapy in metastatic colorectal cancer

Clinical factors are unable to accurately predict the absence of benefit of surgery in patients operated for resection of colorectal liver metastasis

Phase I studies assessing the safety and clinical activity of multiple doses of a NKG2D-based CAR-T therapy, CYAD-01, in metastatic colorectal cancer

Pooled analysis of the surgical treatment for colorectal cancer liver metastases

Small cell carcinoma of the esophagus: a multicentre Rare Cancer Network study

Treatment of colorectal liver metastases: a review

P-057Body Composition (BC), beyond Body Mass Index (BMI) and sarcopenia, has a major prognostic impact on patients with refractory advanced Colorectal Cancer (aCRC)

Combination of nivolumab (nivo) + ipilimumab (ipi) in the treatment of patients (pts) with deficient DNA mismatch repair (dMMR)/high microsatellite instability (MSI-H) metastatic colorectal cancer (mCRC): CheckMate 142 Study

A first-in-human phase I and pharmacokinetic study of CP-4126 (CO-101), a nucleoside analogue, in patients with advanced solid tumours

Feasibility and safety of a therapeutic strategy using selective transarterial radioembolization followed by surgery for hepatocellular carcinoma in cirrhotic patients

Prospective evaluation of the impact of multidisciplinary meetings on the decision making process in gastro-intestinal oncology

Current practice in approaching controversial diagnostic and therapeutic topics in gastroenteropancreatic neuroendocrine neoplasm management. Belgian multidisciplinary expert discussion based on a modified Delphi method

Suchergebnisse filtern